Providing Regulatory Submissions in Electronic and Non-Electronic Format—Promotional Labeling and Advertising Materials for Human Prescription Drugs
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 11, 2022
April 11, 2022
505d9bf5-96ba-4f03-a291-64f5c289be51
Related Documents
Providing Submissions in Electronic Format — Postmarketing Safety Reports
Guidance DocumentApril 27, 2022Center for Drug Evaluation and Research
Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer (DTC) Promotional Labeling and Advertisements
Guidance DocumentDecember 12, 2023Center for Drug Evaluation and Research
Special Protocol Assessment Guidance for Industry
Guidance DocumentApril 16, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox